83 FR 7189 - Agency Information Collection Activities; Submission for OMB Review; Comment Request; Redesign of Existing Data Collection; National Longitudinal Survey of Older Americans Act Participants (NLSOAAP)
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Community Living Federal Register Volume 83, Issue 34 (February 20, 2018)
Administration for Community Living
Federal Register Volume 83, Issue 34 (February 20, 2018)
| Page Range | 7189-7191 | |
| FR Document | 2018-03390 |
[Federal Register Volume 83, Number 34 (Tuesday, February 20, 2018)] [Notices] [Pages 7189-7191] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2018-03390] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration for Community Living Agency Information Collection Activities; Submission for OMB Review; Comment Request; Redesign of Existing Data Collection; National Longitudinal Survey of Older Americans Act Participants (NLSOAAP) AGENCY: Administration for Community Living, HHS. ACTION: Notice. ----------------------------------------------------------------------- SUMMARY: The Administration for Community Living (ACL) is announcing that the proposed collection of information listed below has been submitted to the Office of Management and Budget (OMB) for review and clearance as required under the Paperwork Reduction Act of 1995 (the PRA). This 30-Day notice collects comments on a proposed revision to an existing data collection related to the National Survey of Older Americans Act Participants (NSOAAP). DATES: Submit written comments on the collection of information by March 22, 2018. ADDRESSES: Submit written comments on the collection of information by fax 202-395-5806 or by email to [email protected], Attn: OMB Desk Officer for ACL. FOR FURTHER INFORMATION CONTACT: Heather Menne at 202-795-7733 or [email protected]. SUPPLEMENTARY INFORMATION: In compliance with Section 44 U.S.C. 3507, ACL has submitted the following proposed collection of information to OMB for review and clearance. ACL is requesting approval for three years for a redesign of an existing data collection (OMB Control Number: 0985-0023). The National Longitudinal Survey of Older Americans Act (OAA) Participants (NLSOAAP) information collection will include consumer assessment surveys for the Congregate and Home-delivered meal nutrition programs; Case Management, Homemaker, and Transportation Services; and the National Family Caregiver Support Program. This survey builds on earlier national pilot studies and surveys, as well as performance measurement tools developed by ACL grantees in the Performance Outcomes Measures Project (POMP). Changes identified as a result of these initiatives, public comment, and the input from an expert panel (i.e., comprised of gerontologists, survey methodologists, and OAA program experts), are included in this proposed redesign of an existing data collection. This information will be used by ACL to track performance outcome measures; support budget requests; comply with the GPRA Modernization Act of 2010 (GPRAMA) reporting requirements; provide national benchmark information; and inform program development and management initiatives. This proposed collection is a revision that will replace the currently approved version (OMB Control Number: 0985-0023) by transitioning from a cross-sectional survey to a longitudinal survey. The current National Survey of Older Americans Act Participants (NSOAAP), an exclusively cross-sectional survey, can transition to a longitudinal information collection component by establishing a baseline cohort and conducting follow-up interviews with that cohort at specified time intervals. A baseline cohort can be selected in the same manner as in prior cycles of the cross-sectional NSOAAP. [[Page 7190]] Area Agencies on Aging (AAAs) would be selected with a probability proportional to their size, with some large AAAs sampled with certainty. Random samples of clients within each selected AAA will be sampled from the agencies' client lists. However, in a change from current procedures, the target sample size would be increased from current standards (n = 6000) to account for attrition of individuals over time. For the duration of the longitudinal cohort analysis, the same sample of AAAs and clients should be maintained to preserve the longitudinal nature of the study. Three strategies are key for transforming the current survey into a longitudinal study, while preserving the ability to produce nationally representative cross-sectional estimates of client characteristics at each wave. The three strategies include: (1) A higher initial sample size (n = 6600), (2) an intensive operational campaign to keep track of respondents over time, and (3) limiting the number of waves for each cohort study (e.g., three waves are proposed). Comments in Response to the 60 Day Federal Register Notice A 60-Day notice was published in the Federal Register in Vol. 82, No. 185, Pages 44800-44802, on September 26, 2017 announcing that ACL was requesting approval of a proposed redesign of an existing data collection extension with modifications of a currently approved data collection. ACL received comments from sixty-four (64) organizations and 15 individuals about the Redesigned National Survey of Older Americans Act Participants (NSOAAP). ACL reviewed all of the comments. Two (2) of the comments were deemed not relevant. The first referenced other data collections and not the NSOAAP (i.e., Census), and the other was commentary without reference to the NSOAAP. The majority of the comments that ACL received requested improved methodology for collecting gender identity (e.g., adding questions to understand gender identity/transgender status). ACL plans to conduct cognitive testing of questions in the redesigned information collection tool, including the gender question, to determine whether the questions are interpreted as intended. Based on the cognitive testing of the information collection tool, ACL will determine whether additional changes are necessary. Other public comments supported the: (a) Longitudinal methodology; (b) collection of data on sexual orientation; (c) inclusion of a rotating module on discrimination; and (d) limiting of burden on the Area Agencies on Aging (AAAs). Because these comments were in support of the proposed information collection, no response is needed. Burden Estimates Descriptions of previous National Surveys of OAA Participants can be found under the section on Performance Outcomes on ACL's website at: https://www.acl.gov/programs/performance-older-americans-act-programs. Copies of the survey instruments and data from previous National Surveys of OAA Participants can be found and queried using the AGing Integrated Database (AGID) at https://agid.acl.gov/. The proposed revisions for the National Survey of Older Americans Act Participants may be found on the ACL website at: https://www.acl.gov/about-acl/public-input. The estimated average hour burden per respondent for the Redesigned NSOAAP will change from the 0.80 hour estimate in 2017 to 0.71 hours. This decrease is due to the proposed change of Area Agencies on Aging only providing client lists once at the start of the three years of data collection (compared to annually in the current cross-sectional data collection). ACL estimates the burden of this revised collection of information as follows: Table--Estimated Annualized Burden Hours ---------------------------------------------------------------------------------------------------------------- Respondent/data collection Number of Responses per Average hours per Annual burden activity respondents respondent response hours ---------------------------------------------------------------------------------------------------------------- Baseline ---------------------------------------------------------------------------------------------------------------- Area Agency on Aging: Respondent 250 1.................... 4.0.................. 1,000 selection process. Service Recipients (i.e., Case 4,400 1.................... .6667................ 2,933 Management; Congregate Nutrition; Home-delivered Nutrition; Homemaker; Transportation). National Family Caregiver Support 2,200 1.................... .6667................ 1,467 Program Clients. ---------------------------------------------------------------------------------------------------------------- Year 2 ---------------------------------------------------------------------------------------------------------------- Area Agency on Aging: Respondent 0 0.................... 0.................... 0 selection process. Service Recipients (i.e., Case 4,200 1.................... .6667................ 2,800 Management; Congregate Nutrition; Home-delivered Nutrition; Homemaker; Transportation). National Family Caregiver Support 2,100 1.................... .6667................ 1,400 Program Clients. ---------------------------------------------------------------------------------------------------------------- Year 3 ---------------------------------------------------------------------------------------------------------------- Area Agency on Aging: Respondent 0 0.................... 0.................... 0 selection process. Service Recipients (i.e., Case 4,000 1.................... .6667................ 2,667 Management; Congregate Nutrition; Home-delivered Nutrition; Homemaker; Transportation). National Family Caregiver Support 2,000 1.................... .6667................ 1,333 Program Clients. ----------------------------------------------------------------------------- Total......................... 19,150 Varies............... .710 (weighted mean). 13,600 ---------------------------------------------------------------------------------------------------------------- [[Page 7191]] Dated: February 13, 2018. Mary Lazare, Principal Deputy Administrator. [FR Doc. 2018-03390 Filed 2-16-18; 8:45 am] BILLING CODE 4154-01-P
![Federal Register / Vol. 83, No. 34 / Tuesday, February 20, 2018 / Notices 7189
for the Approval of Respirators (SAF), respirator approval or certain extensions Manufacturers with current approvals
currently Version 9. of approval are required to submit are subject to site audits by the Institute
Respirator manufacturers are the additional fees for necessary testing and or its agents. Audits may occur
respondents (estimated to average 73 evaluation as specified in 42 CFR parts periodically, typically every second
each year over the years 2017–2020). 84.20–22, 84.66, 84.258 and 84.1102. In year, or because of a reported issue.
Upon submission of the SAF, NIOSH 2016, $2,662,329.00 was accepted. NIOSH completed 59 site audits from 92
evaluates their applications for respirator approval holders for the 2016
approval. Respirator manufacturers Applicants are required to provide
test data that shows that the fiscal year. There is an average fee of
submit applications according to their
manufacturer is capable of ensuring that $8,833 for each audit to align with fee
business needs, which depends upon
the respirator is capable of meeting the collection provisions of the Independent
market conditions, technical advances,
and other factors that are not easy to specified requirements in 42 CFR part Offices Appropriations Act of 1952 (31
forecast. The best estimate for the 84. The requirement for submitted test U.S.C. 9701), and OMB Circular A–25
annual number of respondents is the data is likely to be satisfied by standard Revised. There is no cost to respondents
number from the most recent year for testing performed by the manufacturer, other than the time to participate. The
which data exists, 73 in 2016, an and is not required to follow the total estimated burden hours are
increase from 63 in 2014. Those 73 relevant NIOSH Standard Test 118,435. Burden hours have increased
applicants submitted 542 applications Procedures. As additional testing is not due to a moderate increase in the
in 2016, providing the current best required, providing proof that an estimated number of annual responses
estimate. A $200 fee is required for each adequate test has been performed is per respondent.
application. Respondents requesting limited to providing existing paperwork.
ESTIMATED ANNUALIZED BURDEN HOURS
Average
Number of
Number of burden
Type of respondents Form name responses per
respondents per response
respondent (in hours)
Business or other for-profit ............................. Standard Application for the Approval of 73 7 229
Respirators.
Business or other for-profit ............................. Audit ............................................................... 59 1 24
Leroy A. Richardson, existing data collection related to the measurement tools developed by ACL
Chief, Information Collection Review Office, National Survey of Older Americans Act grantees in the Performance Outcomes
Office of Scientific Integrity, Office of the Participants (NSOAAP). Measures Project (POMP). Changes
Associate Director for Science, Office of the DATES: Submit written comments on the identified as a result of these initiatives,
Director, Centers for Disease Control and public comment, and the input from an
collection of information by March 22,
Prevention.
2018. expert panel (i.e., comprised of
[FR Doc. 2018–03385 Filed 2–16–18; 8:45 am]
ADDRESSES: Submit written comments gerontologists, survey methodologists,
BILLING CODE 4163–18–P and OAA program experts), are
on the collection of information by fax
202–395–5806 or by email to OIRA_ included in this proposed redesign of an
submission@omb.eop.gov, Attn: OMB existing data collection. This
DEPARTMENT OF HEALTH AND
Desk Officer for ACL. information will be used by ACL to
HUMAN SERVICES
FOR FURTHER INFORMATION CONTACT: track performance outcome measures;
Administration for Community Living Heather Menne at 202–795–7733 or support budget requests; comply with
Heather.Menne@acl.hhs.gov. the GPRA Modernization Act of 2010
Agency Information Collection (GPRAMA) reporting requirements;
SUPPLEMENTARY INFORMATION: In
Activities; Submission for OMB provide national benchmark
compliance with Section 44 U.S.C.
Review; Comment Request; Redesign 3507, ACL has submitted the following information; and inform program
of Existing Data Collection; National proposed collection of information to development and management
Longitudinal Survey of Older OMB for review and clearance. initiatives.
Americans Act Participants ACL is requesting approval for three This proposed collection is a revision
(NLSOAAP) years for a redesign of an existing data that will replace the currently approved
AGENCY: Administration for Community collection (OMB Control Number: 0985– version (OMB Control Number: 0985–
Living, HHS. 0023). 0023) by transitioning from a cross-
ACTION: Notice. The National Longitudinal Survey of sectional survey to a longitudinal
Older Americans Act (OAA) survey. The current National Survey of
SUMMARY: The Administration for Participants (NLSOAAP) information Older Americans Act Participants
Community Living (ACL) is announcing collection will include consumer (NSOAAP), an exclusively cross-
that the proposed collection of assessment surveys for the Congregate sectional survey, can transition to a
sradovich on DSK3GMQ082PROD with NOTICES
information listed below has been and Home-delivered meal nutrition longitudinal information collection
submitted to the Office of Management programs; Case Management, component by establishing a baseline
and Budget (OMB) for review and Homemaker, and Transportation cohort and conducting follow-up
clearance as required under the Services; and the National Family interviews with that cohort at specified
Paperwork Reduction Act of 1995 (the Caregiver Support Program. This survey time intervals. A baseline cohort can be
PRA). This 30-Day notice collects builds on earlier national pilot studies selected in the same manner as in prior
comments on a proposed revision to an and surveys, as well as performance cycles of the cross-sectional NSOAAP.
VerDate Sep<11>2014 17:55 Feb 16, 2018 Jkt 244001 PO 00000 Frm 00054 Fmt 4703 Sfmt 4703 E:\FR\FM\20FEN1.SGM 20FEN1](https://thefederalregister.org/doc/83_FR_7223/page/1.svg)
![Federal Register / Vol. 83, No. 34 / Tuesday, February 20, 2018 / Notices 7191
Dated: February 13, 2018. instructions for submitting comments. its consideration of comments. The
Mary Lazare, Comments submitted electronically, second copy, which will have the
Principal Deputy Administrator. including attachments, to https:// claimed confidential information
[FR Doc. 2018–03390 Filed 2–16–18; 8:45 am] www.regulations.gov will be posted to redacted/blacked out, will be available
BILLING CODE 4154–01–P the docket unchanged. Because your for public viewing and posted on
comment will be made public, you are https://www.regulations.gov. Submit
solely responsible for ensuring that your both copies to the Dockets Management
DEPARTMENT OF HEALTH AND comment does not include any Staff. If you do not wish your name and
HUMAN SERVICES confidential information that you or a contact information to be made publicly
third party may not wish to be posted, available, you can provide this
Food and Drug Administration such as medical information, your or information on the cover sheet and not
[Docket No. FDA–2016–E–1891] anyone else’s Social Security number, or in the body of your comments and you
confidential business information, such must identify this information as
Determination of Regulatory Review as a manufacturing process. Please note ‘‘confidential.’’ Any information marked
Period for Purposes of Patent that if you include your name, contact as ‘‘confidential’’ will not be disclosed
Extension; PORTRAZZA information, or other information that except in accordance with § 10.20 (21
identifies you in the body of your CFR 10.20) and other applicable
AGENCY: Food and Drug Administration, comments, that information will be disclosure law. For more information
HHS. posted on https://www.regulations.gov. about FDA’s posting of comments to
ACTION: Notice. • If you want to submit a comment public dockets, see 80 FR 56469,
with confidential information that you September 18, 2015, or access the
SUMMARY: The Food and Drug do not wish to be made available to the
Administration (FDA or the Agency) has information at: https://www.gpo.gov/
public, submit the comment as a fdsys/pkg/FR-2015-09-18/pdf/2015-
determined the regulatory review period
written/paper submission and in the 23389.pdf.
for PORTRAZZA and is publishing this
manner detailed (see ‘‘Written/Paper Docket: For access to the docket to
notice of that determination as required
Submissions’’ and ‘‘Instructions’’). read background documents or the
by law. FDA has made the
determination because of the Written/Paper Submissions electronic and written/paper comments
submission of an application to the received, go to https://
Submit written/paper submissions as
Director of the U.S. Patent and www.regulations.gov and insert the
follows:
docket number, found in brackets in the
Trademark Office (USPTO), Department • Mail/Hand delivery/Courier (for
of Commerce, for the extension of a heading of this document, into the
written/paper submissions): Dockets
patent which claims that human ‘‘Search’’ box and follow the prompts
Management Staff (HFA–305), Food and
biological product. and/or go to the Dockets Management
Drug Administration, 5630 Fishers
DATES: Anyone with knowledge that any
Staff, 5630 Fishers Lane, Rm. 1061,
Lane, Rm. 1061, Rockville, MD 20852.
of the dates as published (see the • For written/paper comments Rockville, MD 20852.
SUPPLEMENTARY INFORMATION section) are submitted to the Dockets Management FOR FURTHER INFORMATION CONTACT:
incorrect may submit either electronic Staff, FDA will post your comment, as Beverly Friedman, Office of Regulatory
or written comments and ask for a well as any attachments, except for Policy, Food and Drug Administration,
redetermination by April 23, 2018. information submitted, marked and 10903 New Hampshire Ave., Bldg. 51,
Furthermore, any interested person may identified, as confidential, if submitted Rm. 6250, Silver Spring, MD 20993,
petition FDA for a determination as detailed in ‘‘Instructions.’’ 301–796–3600.
regarding whether the applicant for Instructions: All submissions received SUPPLEMENTARY INFORMATION:
extension acted with due diligence must include the Docket No. FDA–
2016–E–1891 for ‘‘Determination of I. Background
during the regulatory review period by
August 20, 2018. See ‘‘Petitions’’ in the Regulatory Review Period for Purposes The Drug Price Competition and
SUPPLEMENTARY INFORMATION section for of Patent Extension; PORTRAZZA.’’ Patent Term Restoration Act of 1984
more information. Received comments, those filed in a (Pub. L. 98–417) and the Generic
ADDRESSES: You may submit comments timely manner (see ADDRESSES), will be Animal Drug and Patent Term
as follows. Please note that late, placed in the docket and, except for Restoration Act (Pub. L. 100–670)
untimely filed comments will not be those submitted as ‘‘Confidential generally provide that a patent may be
considered. Electronic comments must Submissions,’’ publicly viewable at extended for a period of up to 5 years
be submitted on or before April 23, https://www.regulations.gov or at the so long as the patented item (human
2018. The https://www.regulations.gov Dockets Management Staff between 9 drug product, animal drug product,
electronic filing system will accept a.m. and 4 p.m., Monday through medical device, food additive, or color
comments until midnight Eastern Time Friday. additive) was subject to regulatory
at the end of April 23, 2018. Comments • Confidential Submissions—To review by FDA before the item was
received by mail/hand delivery/courier submit a comment with confidential marketed. Under these acts, a product’s
(for written/paper submissions) will be information that you do not wish to be regulatory review period forms the basis
considered timely if they are made publicly available, submit your for determining the amount of extension
postmarked or the delivery service comments only as a written/paper an applicant may receive.
submission. You should submit two A regulatory review period consists of
sradovich on DSK3GMQ082PROD with NOTICES
acceptance receipt is on or before that
date. copies total. One copy will include the two periods of time: A testing phase and
information you claim to be confidential an approval phase. For human
Electronic Submissions with a heading or cover note that states biological products, the testing phase
Submit electronic comments in the ‘‘THIS DOCUMENT CONTAINS begins when the exemption to permit
following way: CONFIDENTIAL INFORMATION.’’ The the clinical investigations of the
• Federal eRulemaking Portal: Agency will review this copy, including biological product becomes effective
https://www.regulations.gov. Follow the the claimed confidential information, in and runs until the approval phase
VerDate Sep<11>2014 17:55 Feb 16, 2018 Jkt 244001 PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 E:\FR\FM\20FEN1.SGM 20FEN1](https://thefederalregister.org/doc/83_FR_7223/page/3.svg)
Document Created: 2018-02-17 02:29:24
Document Modified: 2018-02-17 02:29:24
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice. | |
| Dates | Submit written comments on the collection of information by March 22, 2018. | |
| Contact | Heather Menne at 202-795-7733 or [email protected] | |
| FR Citation | 83 FR 7189 |
2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR